HIVE:NASDAQHIVE Digital Technologies Ltd Analysis
Data as of 2026-04-08 - not real-time
$1.94
Latest Price
8/10Risk
Risk Level: High
Executive Summary
HIVE Digital Technologies is trading at $1.94, well below its 20‑day SMA of $2.02, 50‑day SMA of $2.21 and the 200‑day SMA of $3.07, indicating a bearish price backdrop despite a modestly bullish MACD histogram. Volatility is extreme at 71.7% over the past 30 days and beta exceeds 2.0, underscoring heightened market sensitivity. The stock appears dramatically undervalued, with a DCF‑derived fair value of roughly $14 and an upside potential of over 200%, while forward P/E sits at a low 2.94 and price‑to‑book is under 1.0. However, operating margins are deeply negative and the company carries a high debt‑to‑equity ratio of 3.23, reflecting significant financial leverage.
Recent announcements of an AI compute and robotics partnership with AMC Robotics and a strategic push into green‑energy data centers provide a clear growth catalyst, supported by strong operating cash flow of $97 million and free cash flow of $96 million. Analysts are overwhelmingly bullish (strong‑buy) with a median target near $5.5, suggesting the market expects a turnaround as the firm leverages its infrastructure assets. The combination of deep undervaluation, positive cash generation, and emerging AI opportunities makes HIVE a high‑risk, high‑reward proposition.
Recent announcements of an AI compute and robotics partnership with AMC Robotics and a strategic push into green‑energy data centers provide a clear growth catalyst, supported by strong operating cash flow of $97 million and free cash flow of $96 million. Analysts are overwhelmingly bullish (strong‑buy) with a median target near $5.5, suggesting the market expects a turnaround as the firm leverages its infrastructure assets. The combination of deep undervaluation, positive cash generation, and emerging AI opportunities makes HIVE a high‑risk, high‑reward proposition.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price hovering just above the $1.73 support level
- Extreme short‑term volatility and high beta
- Pending Q3 earnings release may clarify near‑term momentum
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervaluation versus DCF fair value and forward P/E
- Positive free cash flow and strong operating cash generation
- Strategic AI and robotics partnership expanding revenue opportunities
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Long‑term upside potential exceeding 200% based on fair‑value models
- Sustainable cash flow despite current losses
- Growth trajectory tied to green data‑center expansion and blockchain infrastructure demand
Key Metrics & Analysis
Financial Health
Revenue Growth218.60%
Profit Margin-48.63%
P/E Ratio2.9
ROE-25.17%
ROA-10.78%
Debt/Equity3.23
P/B Ratio0.8
Op. Cash Flow$97.2M
Free Cash Flow$96.3M
Industry P/E16.8
Technical Analysis
TrendBearish
RSI43.6
Support$1.73
Resistance$2.30
MA 20$2.02
MA 50$2.21
MA 200$3.07
MACDBullish
VolumeStable
Fear & Greed Index85.27
Valuation
Fair Value$14.05
Target Price$6.06
Upside/Downside212.50%
GradeUndervalued
TypeBlend
Risk Assessment
Beta2.21
Volatility71.74%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.